Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Selected
COVID-19
Type of publications
Guidelines (1)
NITAG documentation (354)
SAGE documentation (33)
Scientific publications (4)
Systematic reviews (SYSVAC) (1121)
Regions
Africa (59)
Americas (187)
Eastern Mediterranean (10)
Europe (155)
South-East Asia (11)
Western Pacific (36)
Diseases
COVID-19 (1513)
Chikungunya (9)
Cholera (34)
Cytomegalovirus (1)
Dengue (40)
Diphtheria (80)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (68)
Hepatitis A (64)
Hepatitis B (157)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (68)
HIV / AIDS (10)
Human papillomavirus (HPV) (493)
Influenza (581)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (28)
Measles (130)
Meningococcal disease (148)
Moraxella catarrhalis (1)
Mpox (55)
Mumps (46)
Pertussis (105)
Pneumococcal disease (277)
Poliomyelitis (86)
Q fever (1)
Rabies (29)
Rotavirus (117)
RSV (Respiratory syncytial virus) (48)
Rubella (64)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (60)
Tick-borne encephalitis (12)
Tuberculosis (77)
Typhoid (24)
Varicella (71)
Yellow fever (42)
Zika (1)
Show more
Methodological quality (AMSTAR 2)
High (12)
Moderate (8)
Low (116)
Critically low (703)
Not applicable (282)
1513 results found
2021
∙
SAGE
Meeting of Strategic Advisory Group of Experts on Immunization, October 2021: conclusions and recommendations
2021
∙
SAGE
Meeting of the Strategic Advisory Group of Experts on Immunization, 22–24 March 2021: conclusions and recommendations
2021
∙
Comité Nacional de Inmunización (CNI)
Vaccination, prevention against COVID in children under 12 years old in Bolivia
2021
∙
Comité Nacional de Inmunización (CNI)
Vaccination of pregnant women
2021
∙
SAGE
Background document on the Bharat Biotech BBV152 COVAXIN® (COVID-19) vaccine
2021
∙
SAGE
Annexes to the interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
2021
∙
ACIP
Adverse events among children ages 5–11 years after COVID-19 vaccination: updates from v-safe and the Vaccine Adverse Event Reporting System (VAERS)
2021
∙
ATAGI
ATAGI statement on AstraZeneca vaccine in response to new vaccine safety concerns - 8 April, 2021
2021
∙
ACIP
COVID-19 Vaccine Safety Technical (VaST) Work Group
2021
∙
ACIP
Update on Omicron Variant
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register